Form D · Biotechnology
Creative BioTherapeutics LLC
Gurnee, IL · CIK 0001899355
Offering snapshot reported Jul 29, 2025 · SEC filing
- Reported sold
- $947K Offering amount: $10M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Aug 15, 2023 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$150,000 → $947,000
- Reported investors1 → 22
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 29, 2025 | Amendment | $947,000 | $797,000vs Aug 22, 2023 | 22 | SEC filing |
| Aug 22, 2023 | Initial | $150,000 | No comparison | 1 | SEC filing |
| Feb 9, 2023 | Initial | $80,000 | No comparison | 1 | SEC filing |
| Dec 15, 2021 | Initial | $100,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-490382
Source: Form D, filed Jul 29, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Donald Davidson | Executive |
| Anita Kay Davidson | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
200 South Greenleaf St Suite J
Gurnee, IL, 60031
Gurnee, IL, 60031